News and Events
News and Events
It is our ambition to make the world of microbiology work simpler. But simplifying the many intricate processes in and around clinics and laboratories takes more than merely delivering simple solutions.
This is why we make a volume of our accumulated knowledge available for you. Our lab is considered an authoritative entity in our field, and by sharing our insights, we hope to inspire you to simplify.
08 Jul 2024
The C. DIFF QUIK CHEK COMPLETE® test from TECHLAB, Inc., part of the SSI Diagnostica Group, receives the first* European IVDR Certification for combined GDH plus Toxin A/B test
Blacksburg, VA – June 21, 2024 – TECHLAB, Inc., a part of the SSI Diagnostica Group, is pleased to announce that its C. DIFF QUIK CHEK COMPLETE® test has received certification under the European In Vitro Diagnostic Medical Device Regulation (IVDR), a first* for a combined GDH plus toxin A/B test. The C. DIFF QUIK […]
Read article03 May 2024
New Vice President: Mie N. Petersen Spearheading Global Strategy & Corporate Development
SSI Diagnostica Group is promoting Mie Nete Petersen to Vice President of Global Strategy & Corporate Development. She has undertaken a crucial role in developing our strategy and long-term growth ambition. Mie has extensive experience from large companies like Novo Nordisk and Coloplast working with strategy, commercial development and marketing before joining SSI Diagnostica in […]
Read article01 Apr 2024
Welcoming New Head of Global Sales & Marketing for Kits & Consumables
In the effort to continuously strengthen the position with customers and be able to serve the IVD Diagnostics industry with quality diagnostics solutions, SSI Diagnostica Group is unifying its commercial sales and marketing regions for the diagnostics portfolio – kits and consumables. Cara Felish will join SSI Diagnostica Group as new head of this commercial […]
Read article29 Nov 2023
Global Commercial Execution with our partners in the Vaccine and IVD Industry
As part of our strategic focus on the Vaccine & IVD Industry, we’re delighted to announce new colleagues as part of our commercial team. We proudly welcome two dynamic individuals, each bringing a wealth of experience and passion from the clinical diagnostic industry to our organization: Stuart McRoberts will be heading the Global Vaccine & […]
Read article03 Jul 2023
Strengthening the Leadership Team – New Head of Global R&D
SSI Diagnostica Group continues to strengthen the leadership team with the appointment of Finn Albrechtsen as the new Head of Global R&D. Finn has most recently held the CEO position at Vidya Ltd. (VC) as well as VP for R&D and Business Development at Thermo Fisher Scientific Microbiology Division. Prior to that Finn was Snr. […]
Read article31 May 2023
New Chairman of the Board appointed
We are delighted to announce the appointment of our new Chairman of the Board, Nachum (Homi) Shamir. Homi has significant top management and board experience, most recently as the longtime CEO and Chairman of the Board of Luminex Corporation, where he among other things led the successful acquisition of Nanosphere and the sale of the […]
Read article20 Jan 2023
Christina Lindved appointed new Group CEO
The SSI Diagnostica Group (SSID Group) is delighted to announce the appointment of Christina Lindved as its new Group CEO effective from today. Christina has served on the board of Directors at SSID Group since 2018 and has extensive global Clinical Diagnostic leadership experience. Prior to joining SSID Group Christina has held senior executive positions […]
Read article21 Dec 2022
Merry Christmas & Happy New Year
Our office will be closed on Monday, December 26, but otherwise you will be able to get in contact with us as usual.
Read article22 Aug 2022
SSI Diagnostica continues strong growth journey
New acquisition in the IVD industry: SSI Diagnostica continues strong growth journey by merging with Virginia-based TechLab
Read article22 Dec 2022
The U.S. FDA has granted Emergency Use Authorization for CTK Biotech’s ImmuView® COVID-19 Antigen Home Test
Learn more
Read article04 Aug 2022
The first SARS-CoV-2 self test to receive WHO Emergency Use Listing
Our OnSite® COVID-19 Ag Self Test is the FIRST to receive the WHO Emergency Use Listing for a SARS-CoV-2 self test.
Read article21 Feb 2022
The OnSite® COVID-19 Ag Rapid Test has received WHO Emergency Use Listing
See WHO’s Emergency Use Listing
Read article12 Jan 2022
You only find what you look for
How a certain species of the unwelcomed Legionella might be more common than the numbers suggest.
Read article17 Dec 2021
COVID-19 antigen test for self-testing
Get valuable insights into our immune system’s response to COVID-19
Read article16 Dec 2021
QuantiFERON® SARS-CoV-2 is now CE-marked
Get valuable insights into our immune system’s response to COVID-19
Read article22 Oct 2021
New Lot Numbers
Update to lot numbers for all products not part of the culture media portfolio
Read article20 Sep 2021
New website: Simpler for the better
Today, we proudly launch the new SSI Diagnostica corporate website. Here, we want to give our costumers and partners an improved user experience, updated visual design and improved communication. Keeping things simple is no simple task when you operate in a global and regulated market with complex products and a diverse target group. If you […]
Read article18 Sep 2021
Are you doing AST in your laboratory?
Have you seen our dRAST?
Direct and Rapid AST
If not, take a look at this fast and easy instrument for AST. Free up time and space in your lab, load directly from the positive blood culture, and in less than 7 hours you know which antibiotic and in which concentration it is needed.
20 Aug 2021
OnSite COVID-19 Ag test
The OnSite® COVID-19 Ag Rapid Test is for detection of SARS-CoV-2 virus. Easy to use * No equipment needed * Result in 15 minutes * Pre-filled buffer * For nasal and nasopharyngeal specimens
Read articleGet in touch
Please, reach out if you have a question, comment or request.